Amy D Shah1, William L Border, Timothy M Crombleholme, Erik C Michelfelder. 1. Fetal Care Center of Cincinnati, Divisions of Pediatric Cardiology, General, Thoracic, and Fetal Surgery, Cincinnati Children's Hospital and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Abstract
BACKGROUND: The aim of this study was to assess the relationship between cardiomyopathy and recipient twin (RT) outcome in twin-twin transfusion syndrome (TTTS). METHODS: Fetal echocardiography and outcomes data in 62 consecutive pregnancies with TTTS were reviewed. The primary outcome was neonatal RT survival. The severity of RT cardiomyopathy at presentation was assessed by the cardiovascular profile score (CVPS). RT outcomes and odds of survival were compared between groups stratified by CVPS. RESULTS: Overall neonatal survival for all fetuses was 61% (76 of 124). RT survival was 58% (36 of 62). Grouped by CVPS, RT survival was greater (50%) for those with CVPS > or = 9 and even higher (74%) for CVPS of 10. Among the components of the CVPS, atrioventricular valve regurgitation was associated with negative RT outcome. Other factors at presentation were not predictive of RT outcome. CONCLUSIONS: A normal CVPS in the RT in TTTS is predictive of improved survival compared with an abnormal CVPS, even in RTs with minor deductions. Standard clinical staging did not predict outcome. Cardiac assessment by CVPS may improve clinical decision making and the timing of fetal interventions.
BACKGROUND: The aim of this study was to assess the relationship between cardiomyopathy and recipient twin (RT) outcome in twin-twin transfusion syndrome (TTTS). METHODS: Fetal echocardiography and outcomes data in 62 consecutive pregnancies with TTTS were reviewed. The primary outcome was neonatal RT survival. The severity of RT cardiomyopathy at presentation was assessed by the cardiovascular profile score (CVPS). RT outcomes and odds of survival were compared between groups stratified by CVPS. RESULTS: Overall neonatal survival for all fetuses was 61% (76 of 124). RT survival was 58% (36 of 62). Grouped by CVPS, RT survival was greater (50%) for those with CVPS > or = 9 and even higher (74%) for CVPS of 10. Among the components of the CVPS, atrioventricular valve regurgitation was associated with negative RT outcome. Other factors at presentation were not predictive of RT outcome. CONCLUSIONS: A normal CVPS in the RT in TTTS is predictive of improved survival compared with an abnormal CVPS, even in RTs with minor deductions. Standard clinical staging did not predict outcome. Cardiac assessment by CVPS may improve clinical decision making and the timing of fetal interventions.
Authors: D Mahieu-Caputo; F Muller; D Joly; M C Gubler; J Lebidois; L Fermont; Y Dumez; M Dommergues Journal: Fetal Diagn Ther Date: 2001 Jul-Aug Impact factor: 2.587
Authors: Rubén A Quintero; Jan E Dickinson; Walter J Morales; Patricia W Bornick; Carlos Bermúdez; Robert Cincotta; Fung Yee Chan; Mary H Allen Journal: Am J Obstet Gynecol Date: 2003-05 Impact factor: 8.661
Authors: E Michelfelder; W Gottliebson; W Border; M Kinsel; W Polzin; J Livingston; P Khoury; T Crombleholme Journal: Ultrasound Obstet Gynecol Date: 2007-12 Impact factor: 7.299
Authors: Anita J Moon-Grady; Larry Rand; Salvador Gallardo; Kristen Gosnell; Hanmin Lee; Vickie A Feldstein Journal: Am J Obstet Gynecol Date: 2011-09-01 Impact factor: 8.661
Authors: Ahmet A Baschat; Sean B Blackwell; Debnath Chatterjee; James J Cummings; Stephen P Emery; Shinjiro Hirose; Lisa M Hollier; Anthony Johnson; Sarah J Kilpatrick; Francois I Luks; M Kathryn Menard; Lawrence B McCullough; Julie S Moldenhauer; Anita J Moon-Grady; George B Mychaliska; Michael Narvey; Mary E Norton; Mark D Rollins; Eric D Skarsgard; KuoJen Tsao; Barbara B Warner; Abigail Wilpers; Greg Ryan Journal: Obstet Gynecol Date: 2022-05-02 Impact factor: 7.623
Authors: Tim Van Mieghem; Liesbeth Lewi; Léonardo Gucciardo; Philip Dekoninck; Dominique Van Schoubroeck; Roland Devlieger; Jan Deprest Journal: Int J Pediatr Date: 2010-08-08
Authors: Emily C Willner; Henry L Galan; Bettina F Cuneo; Hilary A Hoffman; Bonnie Neltner; Eleanor L Schuchardt; Anis Karimpour-Fard; Shelley D Miyamoto; Carmen C Sucharov Journal: Am J Obstet Gynecol Date: 2021-06-19 Impact factor: 10.693
Authors: Manon Gijtenbeek; Sanne J Eschbach; Johanna M Middeldorp; Frans J C M Klumper; Femke Slaghekke; Dick Oepkes; Monique C Haak Journal: Prenat Diagn Date: 2019-07-17 Impact factor: 3.050